Anaphylaxis and serum sickness in patients receiving omalizumab: reviewing the data in light of clinical experience
- PMID: 25963450
- DOI: 10.1016/j.anai.2015.04.014
Anaphylaxis and serum sickness in patients receiving omalizumab: reviewing the data in light of clinical experience
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical